Modeling of 24-Hour Glucose and Insulin Profiles of Patients With Type 2 Diabetes

被引:38
|
作者
Jauslin, Petra M. [1 ,2 ]
Frey, Nicolas
Karlsson, Mats O. [2 ]
机构
[1] F Hoffmann La Roche Ltd, Dept Biomath, Modeling & Simulat Grp, Biomath Modeling & Simulat,PDIM M,Biomath, CH-4070 Basel, Switzerland
[2] Uppsala Univ, Dept Pharmaceut Biosci, Div Pharmacokinet & Drug Therapy, S-75105 Uppsala, Sweden
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 51卷 / 02期
关键词
NONMEM; glucose homeostasis; type; 2; diabetes; meal test; circadian rhythm;
D O I
10.1177/0091270010362536
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A model able to simultaneously characterize and simulate 24-hour glucose and insulin profiles following multiple meal tests was developed, extending an integrated glucose-insulin model for oral glucose tolerance tests that was previously published. The analysis was based on glucose and insulin measurements from 59 placebo-treated patients with type 2 diabetes. Circadian variations in glucose homeostasis were assessed on relevant parameters based on literature review. They were best described by a nighttime dip in insulin secretion between approximately 9 p.m. and 5 a.m. using a modulator function. The integrated glucose-insulin model has thus been shown to be applicable to real-life situations determined by multiple meals over the course of a day. This provides the basis for the analysis and simulation of long-term glucose and insulin data. The model may also prove useful for understanding antidiabetic drug actions and requirements in the context of circadian changes in glucose-insulin regulation.
引用
收藏
页码:153 / 164
页数:12
相关论文
共 50 条
  • [1] Modeling of 24-hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart
    Roge, Rikke M.
    Klim, Soren
    Kristensen, Niels R.
    Ingwersen, Steen H.
    Kjellsson, Maria C.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (07): : 809 - 817
  • [2] Whole 24-hour continuous glucose monitoring profiles with insulin glargine or oral antidiabetic drug therapy in patients with type 2 diabetes mellitus
    Yale, J. -F.
    Harris, S.
    Stewart, J. A.
    Gerstein, H. C.
    DIABETOLOGIA, 2008, 51 : S431 - S431
  • [3] Empagliflozin Improves 24-Hour Blood Pressure Profiles in Patients With Type 2 Diabetes and Hypertension
    Tikkanen, Ilkka
    Narko, Kirsi
    Zeller, Cordula
    Green, Alexandra
    Salsali, Afshin
    Broedl, Uli C.
    Woerle, Hans J.
    CIRCULATION, 2013, 128 (22)
  • [4] Mean 24-hour glucose and postprandial glucose are lower with insulin lispro mixture 75/25 compared with insulin glargine in patients with type 2 diabetes
    Roach, P
    Malone, JK
    DIABETES, 2005, 54 : A134 - A134
  • [5] Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes
    Nagakura, Jo
    Yamakawa, Tadashi
    Taguri, Masataka
    Tsuchiya, Hirohisa
    Shigematsu, Erina
    Suzuki, Jun
    Morita, Satoshi
    Kadonosono, Kazuaki
    Terauchi, Yasuo
    ENDOCRINE JOURNAL, 2016, 63 (03) : 239 - 247
  • [6] Exenatide significantly improved 24-hour average glucose compared to sitagliptin in patients with type 2 diabetes
    Shenouda, S. K.
    Holcombe, J. H.
    Heilmann, C. R.
    DIABETOLOGIA, 2010, 53
  • [7] Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus
    Herz, M
    Arora, V
    Campaigne, BN
    Scholtz, HE
    Potgieter, MA
    Mollentze, W
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2003, 93 (03): : 219 - 223
  • [8] Mean postprandial and 24-hour glucose are lower with insulin lispro mixture 25/75 compared with insulin glargine in patients with type 2 diabetes mellitus
    Malone, JK
    Roach, P
    DIABETOLOGIA, 2005, 48 : A301 - A302
  • [9] Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes
    Vigeral, C.
    Sola-Gazagnes, A.
    Nejjar, S.
    M'Bemba, J.
    Boitard, C.
    Slama, G.
    Elgrably, F.
    Larger, E.
    DIABETES & METABOLISM, 2011, 37 (06) : 553 - 559
  • [10] Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes
    Mokhlesi, Babak
    Grimaldi, Daniela
    Beccuti, Guglielmo
    Van Cauter, Eve
    DIABETES OBESITY & METABOLISM, 2017, 19 (03): : 452 - 456